









市場行情
/
股票
/
nasdaq-pen
/

Penumbra Inc

PEN

231.540USD

-1.830-0.78%

收盤 10/30, 16:00（美東）報價延遲15分鐘

9.02B總市值

61.09本益比TTM



Penumbra Inc

231.540

-1.830-0.78%

概覽公司財務分析

概覽

公司

財務

分析

關於 Penumbra Inc 公司

Penumbra, Inc. 是一家醫療保健公司。該公司設計、開發、製造和銷售產品，並擁有一系列產品，可解決市場上尚未滿足需求的棘手醫療狀況。該公司專注於開發、製造和銷售供專科醫生和醫療保健提供者使用的產品，以推動改善臨牀和健康結果。該公司專注於開發和構建其產品組合，包括血栓切除術、栓塞術、通路和沉浸式醫療保健技術。該公司關注的常見疾病包括肺栓塞、深靜脈血栓形成、外周動脈閉塞、缺血性中風、急性冠狀動脈綜合徵、與動靜脈移植或瘻相關的血栓、動脈瘤和出血性中風。該公司主要通過其在美國、歐洲、加拿大和澳大利亞的直銷組織以及在特定國際市場的分銷商向醫療保健提供者銷售其產品。

Penumbra Inc簡介



公司代碼PEN

公司名稱Penumbra Inc

上市日期Sep 18, 2015

CEOMr. Adam Elsesser, J.D.

員工數量4500

證券類型Ordinary Share

年結日Sep 18

公司地址One Penumbra Place

城市ALAMEDA

上市交易所NYSE Consolidated

國家United States of America

郵編94502

電話15109952486

網址https://www.penumbrainc.com/

公司代碼PEN

上市日期Sep 18, 2015

CEOMr. Adam Elsesser, J.D.

Penumbra Inc公司高管



名稱

名稱/職務

職務

持股

持股變動

Mr. Adam Elsesser, J.D.

Chairman of the Board, Chief Executive Officer

1.02M

+1.21%

Dr. Arani Bose, M.D.

Director

290.26K

-3.97%

Ms. Johanna Roberts

Executive Vice President, General Counsel, Secretary

51.68K

-1.15%

Ms. Shruthi Narayan

President

26.96K

-4.58%

Mr. Lambert Shiu

Chief Accounting Officer

25.61K

-4.98%

Ms. Janet Leeds

Independent Director

5.49K

-1.06%

Ms. Bridget O'Rourke

Independent Director

4.82K

-1.03%

Ms. Surbhi Sarna

Independent Director

3.15K

-1.84%

Ms. Maggie S. Yuen

Chief Financial Officer

Mr. Thomas C. (Tom) Wilder, III

Presiding Independent Director

名稱

名稱/職務

職務

持股

持股變動

Mr. Adam Elsesser, J.D.

Chairman of the Board, Chief Executive Officer

1.02M

+1.21%

Dr. Arani Bose, M.D.

Director

290.26K

-3.97%

Ms. Johanna Roberts

Executive Vice President, General Counsel, Secretary

51.68K

-1.15%

Ms. Shruthi Narayan

President

26.96K

-4.58%

Mr. Lambert Shiu

Chief Accounting Officer

25.61K

-4.98%

Ms. Janet Leeds

Independent Director

5.49K

-1.06%

收入明細

單位: USD更新時間: 10月6日週一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

業務USD

名稱

營收

佔比

Thrombectomy

230.26M

67.83%

Embolization and Access

109.20M

32.17%

地區USD

名稱

營收

佔比

United States

260.82M

76.83%

International

78.64M

23.17%

業務

地區

業務USD

名稱

營收

佔比

Thrombectomy

230.26M

67.83%

Embolization and Access

109.20M

32.17%

股東統計

更新時間: 10月22日週三

持股股東

股東類型

持股股東

佔比

Fidelity Management & Research Company LLC

12.92%

The Vanguard Group, Inc.

9.88%

BlackRock Institutional Trust Company, N.A.

9.25%

T. Rowe Price Associates, Inc.

3.44%

State Street Investment Management (US)

3.00%

其他

61.51%

持股股東

佔比

Fidelity Management & Research Company LLC

12.92%

The Vanguard Group, Inc.

9.88%

BlackRock Institutional Trust Company, N.A.

9.25%

T. Rowe Price Associates, Inc.

3.44%

State Street Investment Management (US)

3.00%

其他

61.51%

股東類型

持股股東

佔比

Investment Advisor

60.23%

Investment Advisor/Hedge Fund

22.51%

Hedge Fund

5.08%

Individual Investor

3.73%

Pension Fund

1.88%

Research Firm

1.63%

Sovereign Wealth Fund

1.21%

Bank and Trust

0.52%

Private Equity

0.08%

其他

3.13%

機構持股



更新時間: 10月1日週三

報告期間

機構數

持股數

持股佔比

持股變動

2025Q3

844

36.41M

93.36%

-2.48M

2025Q2

864

37.32M

95.72%

-2.83M

2025Q1

878

36.92M

95.33%

-3.44M

2024Q4

834

37.02M

96.10%

-3.78M

2024Q3

813

37.33M

96.12%

-2.93M

2024Q2

796

37.57M

96.93%

+395.13K

2024Q1

777

35.67M

92.18%

-2.09M

2023Q4

759

36.33M

94.13%

-67.98K

2023Q3

737

35.15M

91.46%

-2.09M

2023Q2

719

36.20M

94.64%

-1.94M

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

Fidelity Management & Research Company LLC

5.04M

12.92%

+93.97K

+1.90%

Jun 30, 2025

The Vanguard Group, Inc.

3.85M

9.88%

+185.31K

+5.05%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

3.61M

9.25%

+78.78K

+2.23%

Jun 30, 2025

T. Rowe Price Associates, Inc.

1.34M

3.44%

+164.55K

+13.99%

Jun 30, 2025

State Street Investment Management (US)

1.17M

-26.92K

-2.25%

Jun 30, 2025

Elsesser (Adam)

1.02M

2.62%

+12.18K

+1.21%

Sep 03, 2025

Baillie Gifford & Co.

922.13K

2.36%

+233.13K

+33.84%

Jun 30, 2025

RTW Investments L.P.

863.55K

2.21%

+783.00

+0.09%

Jun 30, 2025

Fidelity Institutional Asset Management

818.24K

2.1%

-76.68K

-8.57%

Jun 30, 2025

Champlain Investment Partners, LLC

743.71K

1.91%

-126.21K

-14.51%

Jun 30, 2025

持股ETF



更新時間: 10月6日週一

機構名稱

佔比

Motley Fool Small-Cap Growth ETF

3.26%

Congress SMid Growth ETF

2.33%

SPDR S&P Health Care Equipment ETF

1.95%

First Trust Indxx Medical Devices ETF

1.84%

ROBO Global Healthcare Technology & Innovation ETF

1.71%

Invesco S&P MidCap Quality ETF

1.59%

Putnam Sustainable Future ETF

1.45%

iShares U.S. Medical Devices ETF

1.21%

First Trust Health Care Alphadex Fund

0.91%

Fidelity Women's Leadership ETF

0.78%

Motley Fool Small-Cap Growth ETF

佔比3.26%

Congress SMid Growth ETF

佔比2.33%

SPDR S&P Health Care Equipment ETF

佔比1.95%

First Trust Indxx Medical Devices ETF

佔比1.84%

ROBO Global Healthcare Technology & Innovation ETF

佔比1.71%

Invesco S&P MidCap Quality ETF

佔比1.59%

Putnam Sustainable Future ETF

佔比1.45%

iShares U.S. Medical Devices ETF

佔比1.21%

First Trust Health Care Alphadex Fund

佔比0.91%

Fidelity Women's Leadership ETF

佔比0.78%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

KeyAI

